Welcome to our dedicated page for DSEY news (Ticker: DSEY), a resource for investors and traders seeking the latest updates and insights on DSEY stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DSEY's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DSEY's position in the market.
Diversey Holdings, Ltd. (NASDAQ: DSEY) reported Q3 2021 results showing a net sales decline of 2.4% year-over-year, attributed to the normalization of infection prevention post-pandemic. Despite this, sales were nearly back to pre-COVID levels, decreasing only 0.4% compared to Q3 2019.
The company posted a net loss of $42.1 million, a significant drop from a net income of $13.0 million in Q3 2020. Adjusted EBITDA remained stable at $106.6 million, maintaining a margin of 16.0%, reflecting cost management efforts.
Diversey Holdings, Ltd. (NASDAQ: DSEY) will announce its third quarter 2021 financial results before the market opens on November 5, 2021. A conference call will follow at 8:30 am ET, where management will discuss the results. Interested parties can join the call by dialing the provided numbers or accessing the webcast through the official link. A replay will be available for three hours post-call until November 19, 2021.
Diversey focuses on hygiene and infection prevention, showcasing a legacy of quality and innovation over 95 years.
Diversey Holdings, Ltd. (NASDAQ: DSEY) announced a private placement of $500 million in 4.625% Senior Notes due 2029. The offering is set to close on or around September 29, 2021. Proceeds will be used to repay existing debt and for general corporate purposes. Interest will be paid semi-annually starting April 1, 2022, with maturity on October 1, 2029. The notes are targeted towards qualified institutional buyers and are not registered under the Securities Act. This press release serves informational purposes and does not constitute a sale or solicitation.
Diversey Holdings, Ltd. (NASDAQ: DSEY) announced plans to offer up to $500 million in senior notes via a private offering. This offering aims to refinance existing senior secured credit facilities amounting to $1,500 million. Proceeds will be allocated to redeem all outstanding 5.625% Senior Notes due in 2025 at a premium redemption price of 101.406% plus accrued interest. The new notes will not be registered under the Securities Act and will be offered only to qualified institutional buyers and non-U.S. persons.
Diversey Holdings, Ltd. (NASDAQ: DSEY) has opened its Innovation Zone Research and Development Center in Fort Mill, S.C. This facility centralizes Diversey’s North American R&D efforts and includes advanced labs for product development in hygiene and infection prevention. President Paul Budsworth emphasized that this investment accelerates innovation, supporting Diversey’s global customer base. Chief Architect Rick Dayton highlighted improved collaboration among R&D teams. The center also facilitates customer engagement, showcasing Diversey’s commitment to advancing cleaning technologies.
Diversey Holdings, Ltd. (NASDAQ: DSEY) announced the appointment of Dr. Rod Hochman to its board of directors, effective September 1, 2021. This decision increases the board's total members to ten. CEO Phil Wieland expressed confidence in Dr. Hochman's extensive healthcare experience, which is expected to facilitate growth within the sector. Dr. Hochman has led Providence, a significant health system, since 2013 and carries numerous leadership accolades, enhancing Diversey’s strategic direction in hygiene and infection prevention.
Diversey Holdings, Ltd. (NASDAQ: DSEY) announced Q2 2021 results, showcasing a 3.9% increase in net sales year-over-year, driven by robust growth in the Food & Beverage sector. The company's net loss was $1.3 million, a significant contrast to the $16.4 million net income in Q2 2020. However, adjusted net income rose to $46.8 million, representing a 20.6% increase from 2020. Despite a decline in overall net sales compared to pre-COVID 2019 levels, adjustments in EBITDA indicated improved cost management. The company remains optimistic about future growth amidst ongoing recovery in various sectors.
Diversey Holdings (NASDAQ: DSEY) has announced its acquisition of Tasman Chemicals, a leading Australian manufacturer of hygiene and cleaning solutions with over 55 years of industry experience. This strategic move aims to enhance Diversey's operational presence in Australia and New Zealand, leveraging Tasman's established manufacturing infrastructure for expanded product offerings. CEO Phil Wieland highlighted the benefits of increased operational flexibility and customer responsiveness, while Tasman’s Managing Director Peter Keech emphasized alignment and potential for ongoing product innovation.
Diversey Holdings, Ltd. (DSEY) will release its second quarter 2021 financial results on August 13, 2021, before market open. A conference call will take place on the same day at 8:30 am ET, where management will discuss the results. Interested participants can join by phone at 1-877-407-0784 or via a live webcast. An audio replay will be available after the call until August 27, 2021. Diversey aims to protect people through hygiene and cleaning solutions, building a legacy of quality and innovation over 95 years.
Diversey Holdings, Ltd. (NASDAQ: DSEY) has announced a strategic alliance with Halomine, Inc., securing a global exclusive license for the patented HaloFilm technology targeting institutional and food and beverage markets. This long-lasting antimicrobial product enhances disinfection by providing up to 30 days of residual efficacy when paired with a weekly chlorine-based disinfectant. Phil Wieland, CEO of Diversey, emphasized the alliance's role in combating infectious diseases, while Halomine's CEO highlighted the broad implications for industry standards.
FAQ
What is the market cap of DSEY (DSEY)?
